Paris, France, September 25, 2008 – The utilization of CADI™ (biological modeling approach and technologies) leads to a new industrial success in CNS diseases. BMSystems filed on Septembers 10, 2008, with CEA life Sciences, a patent application covering new therapeutic strategies and a preclinical evaluation platform in the field of psychiatric disorders.This shared patent illustrates the unique efficacy of BMSystems’ proprietary CADI™ technologies, the excellence of the respective research teams and the successful application of the collaborative CADI™ four steps validation process.
After the successful launch and financing, in 2006, of its spin-off Pherecydes-Pharma (infectious diseases, 2 patents), Bio-Modeling Systems confirms the power of its business strategy to create immediate value through collaborations with partners...
...About the Company:
BMSYSTEMS is an independent research-based biotech company that creates CADI™ models of biological systems (pathologies, embryology, bacterial metabolism, etc.) to generate businesses with immediate applications... [PDF] Bio-Modeling Systems' Press Release -
